HB Wealth Management »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by HB Wealth Management

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by HB Wealth Management from 13F filings

Historical chart of HB Wealth Management investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by HB Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by HB Wealth Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $511k 555k 0.92

More positions owned by HB Wealth Management

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Specialized Funds Div App Etf (VIG)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
American Centy Etf Tr Us Eqt Etf (AVUS)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Apple Put Option (AAPL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr S&p 500 Grwt Etf (IVW)
Spdr Series Trust State Street Spd (SPYG)
Home Depot (HD)
Gmo Etf Trust Gmo Us Quality E (QLTY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)

View all positions for HB Wealth Management

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Jpmorgan Chase & Co
Highbridge Capital Management
DG Capital Management
D. E. Shaw & Co
LMR Partners
Calamos Advisors
Corbyn Investment Management
Bnp Paribas Investment Partners
State of Wisconsin Investment Board
Palisade Capital Management
FMR
Advent Capital Management
Financial Consulate
Morgan Stanley
HB Wealth Management

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1